enGene Therapeutics Inc. (ENGNW) Net income 2022–2025
enGene Therapeutics Inc. (ENGNW) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$117.3MFY2025 · since FY2022: -$24.5M → -$117.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$117.3M | -112.7% |
| FY2024 | -$55.1M | +44.8% |
| FY2023 | -$99.9M | -308.5% |
| FY2022 | -$24.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice